Evidence map›Paper›PMID 42037514›Full record

ReviewJournal of experimental botany2026

Emerging roles of glutaredoxins in plant metabolism.

Anna Moseler, Jean-Philippe Reichheld, Andreas J Meyer

Abstract readReview
In one paragraph

Review in Journal of experimental botany, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anna MoselerINRES-Chemical Signalling, University of Bonn, Bonn D-53117, Germany.ORCID 0000-0003-4641-8093
Jean-Philippe ReichheldLaboratoire Génome et Développement des Plantes, Université Perpignan Via Domitia, Perpignan F-66860, France.ORCID 0000-0001-6884-0602
Andreas J MeyerINRES-Chemical Signalling, University of Bonn, Bonn D-53117, Germany.ORCID 0000-0001-8144-4364

Funding

Agence Nationale de la Recherche 20-CE12-0025Agence Nationale de la Recherche 24-CE20-2677Deutsche Forschungsgemeinschaft 539230919Deutsche Forschungsgemeinschaft 545516367Laboratoire d'Excellence TULIP ANR-10-LABX-41TULIP-Graduate School ANR-18-EUR-0019
6 · The paper itself

Abstract

Glutaredoxins (GRXs) constitute a distinct family within the large thioredoxin superfamily. Based on the historic order of discoveries and structural similarities, GRXs were originally annotated as glutathione-dependent oxidoreductases with a CxxC active site motif. These prototypical GRXs are now clustered as class I. Later, it was discovered that some GRXs, particularly those with the highly conserved active site motif CGFS, coordinate iron-sulfur clusters and exhibit little or no oxidoreductase activity. Throughout the course of evolution across kingdoms, the CGFS-containing GRXs form the most highly conserved class II cluster. Compared with non-plant species, the GRX family in spermatophytes has undergone significant enlargement and diversification, resulting in typically more than 30 isoforms that are separated into four classes. This expansion is largely due to the evolution of new plant-specific class III GRXs or ROXYs, characterized by a central CCxx active site motif. The increasing number of GRX copies in the genome, coupled with the modification of domains and addition of domains with different functions, has resulted in the functional diversification of plant GRXs. In this review, we aim to provide an overview of the established and emerging roles of GRXs in plant metabolism.

Indexed as

GlutaredoxinsPlant ProteinsPlantsEvolution, MolecularGlutaredoxinsPlant ProteinsDevelopmentfoldaseglutaredoxinglutathioneholdaseiron-sulfur clustermetabolismoxidoreductasetranscription factor

Identifiers

PMID42037514
PMCPMC13621322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.